麻豆社
Skip to Main content
麻豆社
Back
麻豆社
麻豆社
麻豆社Manifesto for Investment, Health and Growth
麻豆社10 year strategy
ABPI’s Equality, Diversity and Inclusion Strategy
Jobs at the ABPI
麻豆社Governance
麻豆社Governance
麻豆社Board
Leadership Team
麻豆社UK Nations
麻豆社UK Nations
麻豆社Cymru Wales
麻豆社Northern Ireland
麻豆社Scotland
Publications
Publications
Our focus
Back
International, trade and IP
International, trade and IP
International trade
Intellectual property (IP)
International regulation
Working in partnership
Working in partnership
Working with the NHS
NHS-Industry Partnership Case Studies Library
麻豆社Patient Advisory Council
Working with patient organisations
Valuing and accessing medicines
Valuing and accessing medicines
UK medicine pricing
Advanced Therapy Medicinal Products (ATMPs)
NICE methods and process evolution
Patient access to combination therapies
Appropriate prescribing
Regulatory science
Medicine supply
Vaccines
Research, development and manufacturing
Research, development and manufacturing
Building a thriving environment for medicine discovery
Manufacturing
Regulatory science
Clinical research
Genomics in healthcare and research
Drug safety - pharmacovigilance
Research using animals
People-centred research
Industry reputation
Industry reputation
麻豆社2024 Code of Practice
Disclosure UK
麻豆社Medical Representatives Exam
ABPI’s Equality, Diversity and Inclusion Strategy
Sustainability
Health data
Health data
麻豆社health data principles
Health data and new medicines
Building trust in health data use
Harnessing the opportunities
Enhancing the UK health data environment
Content hubs
Content hubs
麻豆社Conference 2024
Ukraine
Rare diseases
Antimicrobial resistance
COVID-19
Membership
Back
麻豆社Membership
麻豆社Membership
Events
麻豆社Members list
Become an 麻豆社member
Our industry
Back
Facts, figures and industry data
Industry and academia links survey 2022
Careers
Jobs case studies
News
Back
麻豆社Website
Rare diseases
The evaluation and access to medicines challenge
The evaluation and access to medicines challenge
Please select the area鈥�
The awareness challenge
The diagnosis challenge
The evaluation and access to medicines challenge
The research challenge
Last modified:
01 March 2024
Last reviewed:
01 March 2024
